Clinical Trials in Taiwan / NCT06331338
Recruiting Not applicable

Effects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes

NCT06331338 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2024-02-14
Last updated
2025-02-12

Condition(s) studied

Type 2 Diabetes

Investigational drug(s) / intervention(s)

Decision Cycle for Person-Centered Glycemic ManagementTraditional diabetes self-management education

Decision Cycle for Person-Centered Glycemic Management: It is defined as a purposefully designed holistic care intervention that improve self-management .

Traditional diabetes self-management education: Traditional diabetes self-management education content focuses more on teaching relevant knowledge and some skills.

Study summary

Decision cycle for person-centered glycemic management is a new diabetes decision making .It is defined as a purposefully designed holistic care intervention .The goal is to improve the self-care behavior of patients with type 2 diabetes, thereby improving glycated hemoglobin levels and delaying the occurrence of complications.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patients diagnosed with type 2 diabetes by a physician. 2. Age: 18 years or above. 3. Glycated hemoglobin (HbA1c ) test value: 7.5-9.0 % 4. No diabetic oral medications, insulin and glucagon-like peptide-1 were replaced in the outpatient when the case was admitted. 5. No pregnancy during the study period. 6. After the researcher explains the purpose of the research, the research subjects agree to join this researcher. 7. Those who are conscious and able to take care of themselves. 8. There is no diagnostic certificate from the American Psychiatric Association's Diagnostic Manual of Mental Disorders, Fourth Edition (DSM-IV)of all mental illnesses. 9. Those who can communicate in Mandarin and Taiwanese. Exclusion Criteria: 1. Patients diagnosed with type 1 diabetes by a physician. 2. Age: Under 18 years old. 3. Glycated hemoglobin test value: less than 7.5 % and greater than 9.0 % 4. Those who replaced oral diabetes medications, insulin and glucagon-like peptide- 1 at the outpatient at the time of admission. 5. Pregnancy during the study period. 6. Those who are unable to take care of themselves and express themselves.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
National Taiwan University Hospital Hsinchu Taiwan Recruiting

More National Taiwan University Hospital trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06331338 on ClinicalTrials.gov ↗ ← All trials in Taiwan